TY  -  
T1  - Circulating tumor DNA in early-stage breast cancer : personalized biomarkers for occult metastatic disease and risk of relapse? 
SN  -  /  
UR  - http://hdl.handle.net/10138/161935 
T3  -  
A1  - af Hallstrom, Taija M.; Puhka, Maija; Kallioniemi, Olli 
A2  -  
PB  -  
Y1  - 2015 
LA  - eng 
AB  - The availability of blood-based markers topredict response of a solid tumor to treatment, estimate patient prognosis and diagnose relapse well before clinical symptoms arise, is a long-standing hope in clinical oncology. Ideally, assays designed to provide such information should be inexpensive (at least in the foreseeable future), simple, and, of course, predictive of the clinical evolution of the disease. While early research focused on circulating glycosylated tumor-derived protein biomarkers... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - 3111 Biomedicine 
N1  -   
PP  -  
ER  -